Biohaven Ltd.
US ˙ NYSE ˙ VGG1110E1079

SecurityBHVN / Biohaven Ltd.
InstitutionInvesco Ltd.
Latest Disclosed Ownership252,931 shares
Latest Disclosed Value $ 2,139,797
Invesco Ltd. reports 29.87% increase in ownership of BHVN / Biohaven Ltd.

On May 12, 2026 - Invesco Ltd. filed a 13F-HR form disclosing ownership of 252,931 shares of Biohaven Ltd. (US:BHVN) valued at $2,139,796 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 19, 2026 disclosing 194,751 shares of Biohaven Ltd.. This represents a change in shares of 29.87% during the quarter. The current value of the position is $2,731,655 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F BIOHAVEN COM G1110E107 252,931 58,180 29.87 2,140 -2.68 0.0000
2026-02-19 2025-12-31 13F BIOHAVEN COM G1110E107 194,751 72,230 58.95 2,199 19.52 0.0003
2025-11-13 2025-09-30 13F BIOHAVEN COM G1110E107 122,521 32,609 36.27 1,839 45.03 0.0003
2025-08-13 2025-06-30 13F BIOHAVEN COM G1110E107 89,912 21,452 31.34 1,269 -22.92 0.0002
2025-05-12 2025-03-31 13F BIOHAVEN COM G1110E107 68,460 16,646 32.13 1,646 -14.99 0.0003
2025-02-13 2024-12-31 13F BIOHAVEN COM G1110E107 51,814 3,016 6.18 1,935 -20.63 0.0004
2024-11-12 2024-09-30 13F BIOHAVEN COM G1110E107 48,798 365 0.75 2,438 45.03 0.0005
2024-08-13 2024-06-30 13F BIOHAVEN COM G1110E107 48,433 -208,672 -81.16 1,681 -88.04 0.0004
2024-05-14 2024-03-31 13F BIOHAVEN COM G1110E107 257,105 6,835 2.73 14,061 31.28 0.0030
2024-02-13 2023-12-31 13F BIOHAVEN COM G1110E107 250,270 225,013 890.89 10,712 1,532.77 0.0025
2023-11-13 2023-09-30 13F BIOHAVEN COM G1110E107 25,257 -239,966 -90.48 657 -89.66 0.0002
2023-08-11 2023-06-30 13F BIOHAVEN COM G1110E107 265,223 233,256 729.68 6,344 1,355.05 0.0017
2023-05-12 2023-03-31 13F BIOHAVEN COM G1110E107 31,967 14,772 85.91 437 83.19 0.0001
2023-02-13 2022-12-31 13F BIOHAVEN COM G1110E107 17,195 -12,221 -41.55 239 -94.65 0.0001
2022-11-14 2022-09-30 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 29,416 -46,097 -61.05 4,447 -59.58 0.0014
2022-08-15 2022-06-30 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 75,513 -72,419 -48.95 11,002 -37.28 0.0033
2022-05-16 2022-03-31 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 147,932 -77,433 -34.36 17,541 -43.52 0.0045
2022-02-14 2021-12-31 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 225,365 79,404 54.40 31,058 53.18 0.0075
2021-11-15 2021-09-30 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 145,961 66,154 82.89 20,276 161.69 0.0051
2021-08-17 2021-06-30 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 79,807 66,845 515.70 7,748 774.49 0.0019
2021-05-17 2021-03-31 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 12,962 2,604 25.14 886 -0.23 0.0002
2021-02-16 2020-12-31 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 10,358 7,030 211.24 888 309.22 0.0003
2020-11-16 2020-09-30 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 3,328 -12,302 -78.71 217 -81.00 0.0001
2020-08-14 2020-06-30 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 15,630 15,630 1,142 0.0004
2020-05-15 2020-03-31 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 0 -252,670 -100.00 0 -100.00
2020-02-14 2019-12-31 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 252,670 -8,469 -3.24 13,756 26.26 0.0043
2019-11-14 2019-09-30 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 261,139 51,706 24.69 10,895 18.80 0.0028
2019-08-14 2019-06-30 13F/A-1 BIOHAVEN PHARMACTL HLDG CO L COM G11196105 209,433 20,312 10.74 9,171 -5.78 0.0024
2019-08-14 2019-06-30 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 209,433 -16,564 9,171
2019-05-15 2019-03-31 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 189,121 -19,920 -9.53 9,734 25.92 0.0033
2019-02-14 2018-12-31 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 209,041 209,041 7,730 0.0030
2018-05-15 2018-03-31 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 0 -27,723 -100.00 0 -100.00
2018-02-14 2017-12-31 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 27,723 27,723 748 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.